A COMPARISION OF DELTA-9-TETRAHYDROCANNABINOL DEPENDENCE IN C57Bl/6j MICE AND FATTY ACID AMIDE HYDROLASE KNOCK OUT MICE

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Assessment of anandamide's pharmacological effects in mice deficient of both fatty acid amide hydrolase and cannabinoid CB1 receptors.

  2007cited by this paper
• SR 141716 (Rimonabant) precipitates withdrawal in marijuana-dependent mice.

  2006influential reference
• Cannabis Dependence: Understanding the Pharmacology and Physiology of Cannabis Dependence

  2006cited by this paper
• Cannabinoid tolerance and dependence.

  2005cited by this paper
• Structure and function of fatty acid amide hydrolase.

  2005cited by this paper
• Functional disassociation of the central and peripheral fatty acid amide signaling systems.

  2004cited by this paper
• Reversible Inhibitors of Fatty Acid Amide Hydrolase That Promote Analgesia: Evidence for an Unprecedented Combination of Potency and Selectivity

  2004cited by this paper
• Mice lacking fatty acid amide hydrolase exhibit a cannabinoid receptor‐mediated phenotypic hypoalgesia

  2004cited by this paper
• Formation of prostamides from anandamide in FAAH knockout mice analyzed by HPLC with tandem mass spectrometry Published, JLR Papers in Press, January 16, 2004. DOI 10.1194/jlr.M300475-JLR200

  2004cited by this paper
• Increased Seizure Susceptibility and Proconvulsant Activity of Anandamide in Mice Lacking Fatty Acid Amide Hydrolase

  2003cited by this paper
• Intraplantar injection of anandamide inhibits mechanically-evoked responses of spinal neurones via activation of CB2 receptors in anaesthetised rats.

  2003cited by this paper
• Antinociceptive Synergy between Δ9-Tetrahydrocannabinol and Opioids after Oral Administration

  2003influential reference
• Regulation of cannabinoid CB1 receptors in the central nervous system by chronic cannabinoids.

  2003cited by this paper
• Pharmacological activity of fatty acid amides is regulated, but not mediated, by fatty acid amide hydrolase in vivo.

  2002cited by this paper
• International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors

  2002influential reference
• Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor.

  2002cited by this paper
• An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors

  2002cited by this paper
• A review of the published literature into cannabis withdrawal symptoms in human users.

  2002cited by this paper
• Delta 9-tetrahydrocannabinol and cannabinol activate capsaicin-sensitive sensory nerves via a CB1 and CB2 cannabinoid receptor-independent mechanism.

  2002cited by this paper
• Inhibitory effects of SR141716A on G-protein activation in rat brain.

  2001cited by this paper
• Precipitated cannabinoid withdrawal is reversed by Delta(9)-tetrahydrocannabinol or clonidine.

  2001influential reference
• Leptin-regulated endocannabinoids are involved in maintaining food intake

  2001cited by this paper
• Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase

  2001influential reference
• Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716.

  2001cited by this paper
• Opioid and cannabinoid modulation of precipitated withdrawal in delta(9)-tetrahydrocannabinol and morphine-dependent mice.

  2001influential reference
• Absence of delta -9-tetrahydrocannabinol dysphoric effects in dynorphin-deficient mice.

  2001cited by this paper
• Pharmacology and effects of cannabis: A brief review

  2001influential reference
• 2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor

  2001cited by this paper
• Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain.

  2000cited by this paper
• One year follow-up of cannabis dependence among long-term users in Sydney, Australia.

  2000cited by this paper
• Cannabinoid withdrawal is dependent upon PKA activation in the cerebellum

  2000cited by this paper
• Neurobehavioral activity in mice of N-vanillyl-arachidonyl-amide.

  2000cited by this paper
• Self-administration behavior is maintained by the psychoactive ingredient of marijuana in squirrel monkeys

  2000cited by this paper
• Principles of Addiction Medicine

  1999cited by this paper
• Pharmacology of cannabinoid receptor ligands.

  1999influential reference
• Chronic ▵9‐Tetrahydrocannabinol Treatment Produces a Time‐Dependent Loss of Cannabinoid Receptors and Cannabinoid Receptor‐Activated G Proteins in Rat Brain

  1999cited by this paper
• Dependence of mesolimbic dopamine transmission on Δ9-tetrahydrocannabinol

  1999cited by this paper
• Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors.

  1999cited by this paper
• Marijuana withdrawal among adults seeking treatment for marijuana dependence.

  1999cited by this paper
• Changes in aggressive behavior during withdrawal from long-term marijuana use

  1999cited by this paper
• Abstinence symptoms following smoked marijuana in humans

  1999influential reference
• Abstinence symptoms following oral THC administration to humans

  1999influential reference
• Principles of addiction medicine

  1998cited by this paper
• Control of pain initiation by endogenous cannabinoids

  1998cited by this paper
• Assessment of anandamide interaction with the cannabinoid brain receptor: SR 141716A antagonism studies in mice and autoradiographic analysis of receptor binding in rat brain.

  1998cited by this paper
• Cannabinoid-precipitated withdrawal: a time-course study of the behavioral aspect and its correlation with cannabinoid receptors and G protein expression.

  1998cited by this paper
• Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors

  1998cited by this paper
• SR 141716A acts as an inverse agonist to increase neuronal voltage-dependent Ca2+ currents by reversal of tonic CB1 cannabinoid receptor activity.

  1998cited by this paper
• Behavioural and biochemical evidence for signs of abstinence in mice chronically treated with Δ‐9‐tetrahydrocannabinol

  1998influential reference
• Loss of cannabinoid receptor binding and messenger RNA levels and cannabinoid agonist-stimulated [35S]guanylyl-5'O-(thio)-triphosphate binding in the basal ganglia of aged rats.

  1998cited by this paper
• CB1 Receptor Antagonist Precipitates Withdrawal in Mice Exposed to Δ9-Tetrahydrocannabinol

  1998influential reference
• Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism.

  1997cited by this paper
• SR141716A is an inverse agonist at the human cannabinoid CB1 receptor.

  1997cited by this paper
• Δ9-Tetrahydrocannabinol excites rat VTA dopamine neurons through activation of cannabinoid CB1 but not opioid receptors

  1997cited by this paper
• Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety‐like responses in the rat

  1997cited by this paper
• delta 9-Tetrahydrocannabinol is a partial agonist of cannabinoid receptors in mouse brain.

  1997cited by this paper
• Cognitive correlates of long-term cannabis use in Costa Rican men.

  1996cited by this paper
• Improvement of memory in rodents by the selective CB1 cannabinoid receptor antagonist, SR 141716

  1996cited by this paper
• In vivo characterization of a specific cannabinoid receptor antagonist (SR141716A): inhibition of delta 9-tetrahydrocannabinol-induced responses and apparent agonist activity.

  1996influential reference
• Dependence on delta 9-tetrahydrocannabinol: studies on precipitated and abrupt withdrawal.

  1996cited by this paper
• Effects of Chronic Treatment with Δ9-Tetrahydrocannabinol on Cannabinoid-Stimulated [35S]GTPγS Autoradiography in Rat Brain

  1996cited by this paper
• The residual cognitive effects of heavy marijuana use in college students.

  1996cited by this paper
• Cannabinoid precipitated withdrawal by the selective cannabinoid receptor antagonist, SR 141716A.

  1995cited by this paper
• Physical withdrawal in rats tolerant to delta 9-tetrahydrocannabinol precipitated by a cannabinoid receptor antagonist.

  1995cited by this paper
• Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors.

  1995cited by this paper
• The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice.

  1994cited by this paper
• Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: Basic findings from the National Comorbidity Survey.

  1994cited by this paper
• SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

  1994cited by this paper
• Localization of cannabinoid receptor mRNA in rat brain

  1993cited by this paper
• Relating Blood Concentrations of Tetrahydrocannabinol and Metabolites to Pharmacologic Effects and Time of Marijuana Usage

  1993cited by this paper
• Molecular characterization of a peripheral receptor for cannabinoids

  1993cited by this paper
• Bypassing the first-pass effect for the therapeutic use of cannabinoids.

  1993cited by this paper
• Goodman and Gilman's the Pharmacological Basis of Therapeutics, 8th ed

  1992cited by this paper
• Isolation and structure of a brain constituent that binds to the cannabinoid receptor.

  1992cited by this paper
• Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana.

  1992cited by this paper
• Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study

  1991cited by this paper
• Δ9-Tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis

  1990cited by this paper
• Structure of a cannabinoid receptor and functional expression of the cloned cDNA

  1990cited by this paper
• Determination and characterization of a cannabinoid receptor in rat brain.

  1988cited by this paper
• Pharmacology and stereoselectivity of structurally novel cannabinoids in mice.

  1988cited by this paper
• Pharmacokinetics and metabolism of RU 486.

  1987cited by this paper
• Single-dose kinetics of deuterium-labelled cannabinol in man after intravenous administration and smoking.

  1987cited by this paper
• Pharmacokinetics and metabolism of delta 1-tetrahydrocannabinol and other cannabinoids with emphasis on man.

  1986cited by this paper
• Goodman and Gilman's The Pharmacological Basis of Therapeutics

  1986cited by this paper
• Disposition and bioavailability of various formulations of tetrahydrocannabinol in the rhesus monkey.

  1985cited by this paper
• Marijuana effect and delta‐9‐tetrahydrocannabinol plasma level

  1984cited by this paper
• Kinetic study of smoking marijuana

  1982cited by this paper
• Plasma levels of delta 9-tetrahydrocannabinol after intravenous, oral, and smoke administration.

  1981cited by this paper
• Clinical Relevance of Cannabis Tolerance and Dependence

  1981cited by this paper
• Constituents of Cannabis sativa L. XVII. A review of the natural constituents.

  1980cited by this paper
• Toxicology. The Basic Science of Poisons

  1980cited by this paper
• Dissociation of autonomic and cognitive effects of THC in man

  1979cited by this paper
• Observations on the effects of four weeks of heavy marihuana smoking on group interaction and individual behavior.

  1979cited by this paper
• CLINICAL STUDIES OF CANNABIS TOLERANCE AND DEPENDENCE *

  1976influential reference
• Failure obtain “cannabis-directed behavior” and abstinence syndrome in rats chronically treated with Cannabis sativa extracts

  1974cited by this paper
• Anticonvulsant properties of Δ9-tetrahydrocannabinol and other cannabinoids

  1974cited by this paper
• METABOLISM AND DISPOSITION OF Δ9-TETRAHYDROCANNABINOL IN MAN

  1971cited by this paper
• METABOLISM AND DISPOSITION OF TETRAHYDROCANNABINOLS IN NÄIVE SUBJECTS AND CHRONIC MARIJUANA USERS

  1971cited by this paper
• Chemistry and pharmacology of marijuana.

  1971influential reference
• The metabolism and excretion of Δ9-tetrahydrocannabinol in the rat☆☆☆

  1971cited by this paper

• No citing papers are available for this paper.